Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the JAK2/STAT3 Signaling Pathway
Human Gene Therapy · 2023
DOI: 10.1089/hum.2023.046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2023. Verfasst von Yi-Chao Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, P.R. China. Hauptthemen laut MEDLINE: Cullin Proteins, Colorectal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
The highly conserved ribosomal protein L34 ( RPL34 ) has been reported to play an essential role in the progression of diverse malignancies. RPL34 is aberrantly expressed in multiple cancers, although its significant in colorectal cancer (CRC) is currently unclear. Here, we demonstrated that RPL34 expression was higher in CRC tissues than in normal tissues. Upon RPL34 overexpression, the ability of proliferation, migration, invasion, and metastasis of CRC cells were significantly enhanced in vitro and in vivo . Furthermore, high expression of RPL34 accelerated cell cycle progression, activated the JAK2/STAT3 signaling pathway, and induced the epithelial-to-mesenchymal transition (EMT) program. Conversely, RPL34 silencing inhibited the CRC malignant progression. Utilizing immunoprecipitation assays, we identified the RPL34 interactor, the cullin-associated NEDD8-dissociated protein 1 ( CAND1 ), which is a negative regulator of cullin-RING ligases. CAND1 overexpression reduced the ubiquitin level of RPL34 and stabilized RPL34 protein. CAND1 silencing in CRC cells resulted in a decrease in the ability of proliferation, migration, and invasion. CAND1 overexpression promoted CRC malignant phenotypes and induced EMT, and RPL34 knockdown rescued CAND1 -induced CRC progression. In summary, our study indicates that RPL34 acts as a mediator, is stabilized by CAND1 , and promotes proliferation and metastasis, in part, through the activation of the JAK2/STAT3 signaling pathway and induction of EMT in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, P.R. China.
ORCID-Profile: Chao-Liu Dai
Zitieren
APA
Liang, Y. C., Li, R., Bao, S. R., Li, Z. L., Yin, H. Z., & Dai, C. L. (2023). Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the JAK2/STAT3 Signaling Pathway. Human Gene Therapy. https://doi.org/10.1089/hum.2023.046
Vancouver
Liang YC, Li R, Bao SR, Li ZL, Yin HZ, Dai CL. Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the JAK2/STAT3 Signaling Pathway. Human Gene Therapy. 2023. doi:10.1089/hum.2023.046
BibTeX
@article{Liang2023,
author = {Liang, Yi-Chao and Li, Rui and Bao, Shu-Rui and Li, Zhi-Long and Yin, Hong-Zhuan and Dai, Chao-Liu},
title = {Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the JAK2/STAT3 Signaling Pathway},
journal = {Human Gene Therapy},
year = {2023},
doi = {10.1089/hum.2023.046}
}
EUVIMED